ClinicalTrials.Veeva

Menu

Identification of Biomarkers in the Legal Medical Skin Wounds

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Unknown

Conditions

Legal Medical Skin Wounds

Treatments

Other: autopsy

Study type

Observational

Funder types

Other

Identifiers

NCT02898636
9552 (Other Identifier)

Details and patient eligibility

About

Identify the cytokine or combination of cytokines, with the best diagnostic performance to characterize the vital nature of a skin wound in the body.

Full description

Determining the vitality of skin wounds, that is to say their antemortem character, is an important issue in forensic pathology. The only criterion vitality currently recognized (but whose diagnostic performance remains limited) is the microscopic demonstration of an inflammatory infiltrate of neutrophils. The search for more reliable diagnostic biomarkers is required. By their early expression of the injury site, inflammatory cytokines are potential candidates and their quantification in injured skin could optimize the diagnosis of vitality injury.

The objective is to identify the cytokine or combination of cytokines, with the best diagnostic performance to characterize the vital nature of a skin wound in the body.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult died 18 years or more
  • Having at least one recent ante-mortem skin wound (occurring less than 4 hours prior to death)
  • Hours of death and the establishment of the ante-mortem wound known (date, hours and minutes)

Exclusion criteria

  • Immunocompromised patients (HIV infection, immunosuppressive therapy ...)
  • Putrefaction signs (abdominal patch of green ...)

Trial contacts and locations

1

Loading...

Central trial contact

Pierre-Antoine PEYRON, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems